Mitochondrial p53 prompts Bak and causes disruption of a Bak-Mcl1 advanced.

 

• The tumour suppressor exercise of the p53 protein has been defined by its means to induce apoptosis in response to quite a lot of mobile stresses.

 

 

• Thus, understanding the mechanism by which p53 features within the execution of cell demise pathways is of appreciable significance in most cancers biology.

 

 

• Latest research have indicated that p53 has a direct signalling position at mitochondria within the induction of apoptosis, though the mechanisms concerned usually are not utterly understood.

DNA Polymerase for PAGE Enzyme

 

• Right here we present that, after cell stress, p53 interacts with the pro-apoptotic mitochondrial membrane protein Bak. Interplay of p53 with Bak causes oligomerization of Bak and launch of cytochrome c from mitochondria.

 

Guanine Nucleotide Exchange Factor For Rab-3A (RAB3IL1) Antibody

 

• Notably, we present that formation of the p53-Bak advanced coincides with lack of an interplay between Bak and the anti-apoptotic Bcl2-family member Mcl1. These outcomes are in step with a mannequin through which p53 and Mcl1 have opposing results on mitochondrial apoptosis by interacting with, and modulating the exercise of, the demise effector Bak.

 

VHL antibody
70R-9757	Fitzgerald	50 ug	EUR 560.4
Description: Affinity purified rabbit polyclonal VHL antibody

VHL Antibody
ABF6292	Lifescience Market	100 ug	EUR 525.6

VHL Antibody
ABD6104	Lifescience Market	100 ug	EUR 525.6

VHL Antibody
32075-100ul	SAB	100ul	EUR 302.4

VHL Antibody
AF6292	Affbiotech	200ul	EUR 420

VHL Antibody
1-CSB-PA991849	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:50-1:200

VHL Antibody
DF6104	Affbiotech	200ul	EUR 420

VHL Antibody
CSB-PA025852KA01HU-	Cusabio	each	EUR 402
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

VHL Antibody
CSB-PA025852KA01HU-100ul	Cusabio	100ul	EUR 466.8
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

VHL Antibody
1-CSB-PA060067	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000

VHL Antibody
1-CSB-PA071125	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

VHL Antibody
1-CSB-PA876839	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:50-300, ELISA:1:10000-20000

VHL Antibody
F49681-0.05ML	NSJ Bioreagents	0.05 ml	EUR 140.25
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.

VHL Antibody
F49681-0.2ML	NSJ Bioreagents	0.2 ml	EUR 322.15
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.

VHL Antibody
F49682-0.08ML	NSJ Bioreagents	0.08 ml	EUR 140.25
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.

VHL Antibody
F49682-0.4ML	NSJ Bioreagents	0.4 ml	EUR 330.65
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.

VHL Antibody
R35773-100UG	NSJ Bioreagents	100 ug	EUR 339.15
Description: Additional name(s) for this target protein: Von Hippel-Lindau tumor suppressor, VHL1

anti- VHL antibody
FNab09402	FN Test	100µg	EUR 658.5
Description: Antibody raised against VHL

anti- VHL antibody
FNab10175	FN Test	100µg	EUR 606.3
Description: Antibody raised against VHL

Human VHL Antibody
32825-05111	AssayPro	150 ug	EUR 313.2

VHL (pS68) Antibody
abx219320-100ug	Abbexa	100 ug	EUR 526.8

VHL Polyclonal Antibody
46866-100ul	SAB	100ul	EUR 302.4

VHL Polyclonal Antibody
46866-50ul	SAB	50ul	EUR 224.4

VHL Polyclonal Antibody
ABP56500-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68

VHL Polyclonal Antibody
ABP56500-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68

VHL Polyclonal Antibody
ABP56500-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68

VHL Polyclonal Antibody
ABP60891-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50

VHL Polyclonal Antibody
ABP60891-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50

VHL Polyclonal Antibody
ABP60891-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50

VHL Conjugated Antibody
C32075	SAB	100ul	EUR 476.4

VHL Polyclonal Antibody
ES7499-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against VHL from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

VHL Polyclonal Antibody
ES7499-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against VHL from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

VHL Polyclonal Antibody
ES8746-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against VHL from Human. This antibody is tested and validated for IHC, WB, ELISA

VHL Polyclonal Antibody
ES8746-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against VHL from Human. This antibody is tested and validated for IHC, WB, ELISA

VHL (Phospho- Ser68) Antibody
ABF8334	Lifescience Market	100 ug	EUR 525.6

Polyclonal VHL Antibody (C-term)
APR10723G	Leading Biology	0.1ml	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human VHL (C-term). This antibody is tested and proven to work in the following applications:

VHL (Phospho-Ser68) Antibody
12654-100ul	SAB	100ul	EUR 302.4

VHL (Phospho-Ser68) Antibody
12654-50ul	SAB	50ul	EUR 224.4

Human VHL Antibody (Biotin Conjugate)
32825-05121	AssayPro	150 ug	EUR 442.8

VHL (phospho Ser68) Polyclonal Antibody
ABP56499-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68

VHL (phospho Ser68) Polyclonal Antibody
ABP56499-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68

VHL (phospho Ser68) Polyclonal Antibody
ABP56499-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68

VHL (phospho Ser68) Polyclonal Antibody
ES7498-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against VHL (phospho Ser68) from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

VHL (phospho Ser68) Polyclonal Antibody
ES7498-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against VHL (phospho Ser68) from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

Von Hippel Lindau Tumor Suppressor (VHL) Antibody
20-abx326550	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Von Hippel Lindau Tumor Suppressor (VHL) Antibody
20-abx323201	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Von Hippel Lindau Tumor Suppressor (vHL) Antibody
20-abx175113	Abbexa	EUR 1095.60 EUR 560.40	1 mg 200 ug

Von Hippel Lindau Tumor Suppressor (VHL) Antibody
20-abx210322	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Von Hippel Lindau Tumor Suppressor (VHL) Antibody
20-abx211119	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Von Hippel Lindau Tumor Suppressor (vHL) Antibody
20-abx131162	Abbexa	EUR 543.60 EUR 159.60 EUR 1562.40 EUR 744.00 EUR 410.40	100 ug 10 ug 1 mg 200 ug 50 ug

Monoclonal VHL Antibody (monoclonal) (M01), Clone: 1G12
APR10724G	Leading Biology	0.1mg	EUR 580.8
Description: A Monoclonal antibody against Human VHL (monoclonal) (M01). The antibodies are raised in mouse and are from clone 1G12. This antibody is applicable in WB and IF, E

VHL/ Rat VHL ELISA Kit
ELA-E1894r	Lifescience Market	96 Tests	EUR 1063.2

Vhl/ Rat Vhl ELISA Kit
ELI-06080r	Lifescience Market	96 Tests	EUR 1063.2

Human VHL AssayLite Antibody (RPE Conjugate)
32825-05151	AssayPro	150 ug	EUR 513.6

Human VHL AssayLite Antibody (APC Conjugate)
32825-05161	AssayPro	150 ug	EUR 513.6

Human VHL AssayLite Antibody (FITC Conjugate)
32825-05141	AssayPro	150 ug	EUR 513.6

Human VHL AssayLite Antibody (PerCP Conjugate)
32825-05171	AssayPro	150 ug	EUR 565.2

Anti-VHL antibody
PAab09402	Lifescience Market	100 ug	EUR 463.2

Anti-VHL antibody
STJ118733	St John's Laboratory	100 µl	EUR 332.4

Anti-VHL antibody
STJ113440	St John's Laboratory	50 µl	EUR 332.4
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.

Anti-VHL antibody
STJ113742	St John's Laboratory	100 µl	EUR 332.4
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.

Anti-VHL antibody
STJ26089	St John's Laboratory	100 µl	EUR 332.4
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.

Anti-VHL antibody
STJ70964	St John's Laboratory	100 µg	EUR 430.8

Anti-VHL Antibody
STJ502735	St John's Laboratory	100 µg	EUR 571.2

Anti-VHL antibody
STJ96241	St John's Laboratory	200 µl	EUR 236.4
Description: Rabbit polyclonal to VHL.

Anti-VHL antibody
STJ98809	St John's Laboratory	200 µl	EUR 236.4
Description: Rabbit polyclonal to VHL.

VHL (Phospho-Ser68) Polyclonal Conjugated Antibody
C12654	SAB	100ul	EUR 476.4

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx239402-100ug	Abbexa	100 ug	EUR 610.8

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx219331-100ug	Abbexa	100 ug	EUR 526.8

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx012353-100ug	Abbexa	100 ug	EUR 526.8

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
20-abx000699	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx125410-50ul	Abbexa	50 ul	EUR 427.2

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
20-abx126781	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
20-abx137392	Abbexa	EUR 844.80 EUR 393.60 EUR 276.00	100 ug 20 ug 5 ug

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx117007-100ug	Abbexa	100 ug	EUR 560.4

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx032864-400ul	Abbexa	400 ul	EUR 627.6

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx032864-80l	Abbexa	80 µl	EUR 343.2

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx032865-400ul	Abbexa	400 ul	EUR 627.6

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx032865-80l	Abbexa	80 µl	EUR 343.2

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx431703-200ul	Abbexa	200 ul	EUR 460.8

 

 

SirT3 suppresses hypoxia inducible issue 1α and tumor development by inhibiting mitochondrial ROS manufacturing.

 

 

• The position of oncoproteins and tumor suppressor proteins in selling the malignant transformation of mammalian cells by affecting properties reminiscent of proliferative signalling, cell cycle regulation and altered adhesion is effectively established.

 

Taq DNA Polymerase (Recombinant)

 

• Chemical compounds, viruses and radiation are additionally typically accepted as brokers that generally induce mutations within the genes encoding these most cancers-causing proteins, thereby giving rise to most cancers. Nevertheless, more moderen proof signifies the significance of two advertditional key components imposed on proliferating cells which can be concerned in transformation to malignancy and these are hypoxia and/or aggravating circumstances of nutrient deprivation (e.g. lack of glucose).

 

 

 

 

• These two further triggers can provoke and promote the method of malignant transformation when a low share of cells overcome and escape mobile senescence. It’s turning into obvious that hypoxia causes the progressive elevation in mitochondrial ROS production (continual ROS) which over time results in stabilization of cells through elevated HIF-2alpha expression, enabling cells to outlive with sustained ranges of elevated ROS.

 

 

Recombination Signal Binding Protein For Immunoglobulin Kappa J Region (RBPJ) Antibody

 

• In cells below hypoxia and/or low glucose, DNA mismatch restore processes are repressed by HIF-2alpha and so they frequently accumulate mitochondrial ROS-induced oxidative DNA injury and rising numbers of mutations driving the malignant transformation course of.

 

 

 

• Latest proof additionally signifies that the ensuing mutated most cancers-causing proteins suggestions to amplify the method by immediately affecting mitochondrial operate in combinatorial ways in which intersect to play a serious position in selling a vicious spiral of malignant cell transformation.

 

 

 

• Consequently, many malignant course ofes contain intervals of elevated mitochondrial ROS manufacturing when a number of cells survive the extra frequent technique of oxidative injury induced cell senescence and demise. The few cells escaping elimination emerge with oncogenic mutations and survive to change into immortalized tumors.

 

 

 

• This evaluation focuses on evidence highlighting the position of mitochondria as drivers of elevated ROS manufacturing throughout malignant transformation and therefore, their potential as targets for most cancers remedy. The evaluation is organized into 5 fundamental sections regarding totally different features of “mitochondrial malignancy”.

 

 

 

• The primary considerations the features of mitochondrial ROS and its significance as a pacesetter for cell development versus senescence and demise. The second considers the obtainable proof that mobile stress within the type of hypoxic and/or hypoglycaemic conditions signify two of the main triggering occasions for most cancers and the way oncoproteins reinforce this course of by altering gene expression to deliver a couple of frequent set of modifications in mitochondrial operate and exercise in most cancers cells.

 

 

 

• The third part presents proof that oncoproteins and tumor suppressor proteins bodily localize to the mitochondria in most cancers cells the place they immediately regulate malignant mitochondrial packages, together with apoptosis.

 

 

 

 

• The fourth part covers frequent mutational modifications within the mitochondrial genome as they relate to malignancy and the connection to the opposite three areas. The final part considerations the relevance of those findings, their significance and significance for novel focused approaches to anti–most cancers remedy and selective triggering in most cancers cells of the mitochondrial apoptotic pathway.

 

Alpha-bungarotoxin CF488a
9-00005	Biotium	Ask for price Ask for price	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF568
9-00006	Biotium	Ask for price Ask for price	500uG 100uG
Description: Minimum order quantity: 1 unit of 500uG

Alpha-bungarotoxin, CF568
9-00006	Biotium	Ask for price Ask for price	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF594
9-00007	Biotium	Ask for price Ask for price	500uG 100uG
Description: Minimum order quantity: 1 unit of 500uG

Alpha-bungarotoxin CF594
9-00007	Biotium	Ask for price Ask for price	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF633
9-00009	Biotium	Ask for price Ask for price	500uG 100uG
Description: Minimum order quantity: 1 unit of 500uG

Alpha-bungarotoxin, CF633
9-00009	Biotium	Ask for price Ask for price	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin
00010-1	Biotium	1MG	EUR 201.6
Description: Minimum order quantity: 1 unit of 1MG

Fluorescein-Alpha-bungarotoxin
00011	Biotium	500uG	EUR 440.4
Description: Minimum order quantity: 1 unit of 500uG

Tetramethylrhodamine-Alpha-bungarotoxin
00012	Biotium	500uG	EUR 459.6
Description: Minimum order quantity: 1 unit of 500uG

Fluorescein-alpha-bungarotoxin: (10x50ug)
00013	Biotium	10ST	EUR 500.4
Description: Minimum order quantity: 1 unit of 10ST

Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug)
00014	Biotium	10ST	EUR 559.2
Description: Minimum order quantity: 1 unit of 10ST

Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug)
00015	Biotium	500uG	EUR 559.2
Description: Minimum order quantity: 1 unit of 500uG

Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug)
00016	Biotium	10ST	EUR 627.6
Description: Minimum order quantity: 1 unit of 10ST

Biotin-xx-a-bungarotoxin
00017	Biotium	500uG	EUR 519.6
Description: Minimum order quantity: 1 unit of 500uG

Alpha-Bungarotoxin, CF555 conjugate
9-00018	Biotium	Ask for price Ask for price	500uG 100ug
Description: Minimum order quantity: 1 unit of 500uG

Alpha-Bungarotoxin, CF555 conjugate
9-00018	Biotium	Ask for price Ask for price	500uG 100ug
Description: Minimum order quantity: 1 unit of 100ug

Biotin-cAMP, diisopropylethylammonium salt:
00020	Biotium	1MG	EUR 376.8
Description: Minimum order quantity: 1 unit of 1MG

Biotin-cAMP, diisopropylethylammonium salt: (20x50ug)
00020-1	Biotium	20ST	EUR 501.6
Description: Minimum order quantity: 1 unit of 20ST

Biotin-cGMP, diisopropylethylammonium salt:
00021	Biotium	1MG	EUR 412.8
Description: Minimum order quantity: 1 unit of 1MG

Biotin-cGMP, diisopropylethylammonium salt: (20x50ug)
00021-1	Biotium	20ST	EUR 537.6
Description: Minimum order quantity: 1 unit of 20ST

Cyanine 644-cAMP:
00022	Biotium	1MG	EUR 589.2
Description: Minimum order quantity: 1 unit of 1MG

Cyanine 644-cAMP: (20x50ug)
00022-1	Biotium	20ST	EUR 750
Description: Minimum order quantity: 1 unit of 20ST

Fluorescein Methotrexate, triammonium salt:
00023	Biotium	1MG	EUR 337.2
Description: Minimum order quantity: 1 unit of 1MG

Staurosporine
00025	Biotium	100uG	EUR 166.8
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF543
00026	Biotium	500uG	EUR 592.8
Description: Minimum order quantity: 1 unit of 500uG

Rhodamine phalloidin 300u
00027	Biotium	300	EUR 414
Description: Minimum order quantity: 1 unit of 300

Biotin-xx-phalloidin
00028	Biotium	100U	EUR 513.6
Description: Minimum order quantity: 1 unit of 100U

Fluorescein-phalloidin
00030	Biotium	300U	EUR 414
Description: Minimum order quantity: 1 unit of 300U

Rhodamine 110 phalloidin
00032	Biotium	300ST	EUR 414
Description: Minimum order quantity: 1 unit of 300ST

Sulforhodamine 101 (Texas-Red) Phalloidin
00033	Biotium	300EU	EUR 414
Description: Minimum order quantity: 1 unit of 300EU

Phalloidin, CF405M
00034	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF405M
00034-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

CF488A-cAMP
00036	Biotium	100ug	EUR 206.4
Description: Minimum order quantity: 1 unit of 100ug

CF640R-cAMP
00037	Biotium	100ug	EUR 206.4
Description: Minimum order quantity: 1 unit of 100ug

Phalloidin, CF555
00040	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF555
00040-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF647
00041	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF647
00041-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF488A
00042	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF488A
00042-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF543
00043	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF543
00043-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF568
00044	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF568
00044-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF594
00045	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF594
00045-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF633
00046	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF633
00046-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF660R
00047	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF660R
00047-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF680R
00048	Biotium	300U	EUR 559.2
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF680R
00048-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF350
00049	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF350
00049-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF640R
00050	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF640R
00050-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF532
00051	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF532
00051-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF660C
00052	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF660C
00052-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF680
00053	Biotium	300U	EUR 559.2
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF680
00053-T	Biotium	50U	EUR 176.4
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF430
00054	Biotium	300U	EUR 538.8
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF430
00054-T	Biotium	50U	EUR 166.8
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF440
00055	Biotium	300U	EUR 538.8
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF440
00055-T	Biotium	50U	EUR 166.8
Description: Minimum order quantity: 1 unit of 50U

Cholera Toxin Subunit B, CF488A conjugate
00070	Biotium	100ug	EUR 313.2
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF568 conjugate
00071	Biotium	100ug	EUR 313.2
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF594 conjugate
00072	Biotium	100ug	EUR 313.2
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF640R conjugate
00073	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF532 conjugate
00074	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF543 conjugate
00075	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF620R conjugate
00076	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF633 conjugate
00077	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF660R conjugate
00078	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF680R conjugate
00079	Biotium	100ug	EUR 338.4
Description: Minimum order quantity: 1 unit of 100ug

Human Transferrin, CF488A conjugate
00081	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF543 conjugate
00082	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF568 conjugate
00083	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF594 conjugate
00084	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF640R conjugate
00085	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF680R conjugate
00086	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF750 conjugate
00087	Biotium	1mg	EUR 186
Description: Minimum order quantity: 1 unit of 1mg

HIV-1 tat recombinant antigen
00110-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 tat recombinant antigen
00110-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 GAG P24 Recombinant Antigen
00111-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 GAG P24 Recombinant Antigen
00111-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

quotation: istanbul escort